Minimum Bactericidal Concentration
Minimum Bactericidal Concentration - Related Videos
05:16
A Microtiter Plate Method to Assess the Minimum Inhibitory Concentration of an Antibiotic
0 Views •
2025
This video demonstrates a microtiter plate-based method for determining the Minimum Inhibitory Concentration (MIC) of test antibiotics against bacteria. Upon adding a suspension of the bacterial pathogen Pseudomonas aeruginosa to a microtiter plate containing serial dilutions of a test antibiotic, and an inhibitor of the production of pyomelanin by the bacteria, the optical density of the wells is measured to compute the minimum inhibitory concentration of the antibiotic, and the impact of the...
01:31
Determining the Minimum Inhibitory Concentration of Enrofloxacin Against Avian Pathogenic E. coli
0 Views •
2026
Begin with a suspension of avian pathogenic E. coli or APEC in growth media.APEC is a Gram-negative bacterium that infects poultry by entering through the respiratory tract.After breaching the mucosal layer, APEC adhere to epithelial cells, multiply locally, and disrupt the epithelial barrier to enter the bloodstream. The bacteria then spread to multiple organs, causing systemic infection.Add an equal volume of the bacterial suspension to each well of a multi-well plate containing increasing...
05:40
A Serum Bactericidal Assay for the Complement-Mediated Bactericidal Activity of Antibodies
0 Views •
2025
This video demonstrates a technique to evaluate the complement-mediated bactericidal activity of antibodies present in serum. This approach combines isolated serum with pathogenic bacteria and exogenous complement proteins. Upon incubation, the bacteria are grown on an agar plate, and the produced colonies are quantified to measure the serum bactericidal titer.
01:15
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
0 Views •
2025
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
02:55
Determining the Role of Vitronectin in Bacterial Resistance to Bactericidal Activity of Human Serum
0 Views •
2025
This video demonstrates the role of vitronectin, a human serum glycoprotein, on bacterial resistance. Antibodies in the serum interact with bacterial surface proteins, activating complement proteins and forming the membrane attack complex, causing bacterial cell lysis. Vitronectin binding on bacterial membrane protein prevents the membrane attack complex formation, resulting in bacterial survival.
FAQs
The drug-free agar step separates killing from temporary growth suppression. A sample may show no visible growth during broth dilution because the agent inhibits multiplication, yet surviving cells can resume growth after transfer to an agent-free environment. When no colonies appear, the result supports loss of viability under the tested conditions.
Comparing MBC with the minimum inhibitory concentration, or MIC, adds interpretive detail to antimicrobial testing. MIC indicates that visible growth has been suppressed, whereas MBC is based on the subsequent absence of colony growth on drug-free agar. The comparison helps determine whether an agent primarily inhibits growth or produces bactericidal activity.
A defined bacterial population provides the reference basis for interpreting the lowest effective concentration. Using a specified population allows antibacterial agents, materials, coatings, or delivery systems to be evaluated against a consistent test target. This is especially useful when bioengineering studies compare antimicrobial performance across different engineered designs.
Testing across antibacterial agents, antimicrobial materials, and surface coatings produces concentration-based measurements of bactericidal performance. Researchers can compare the resulting values to identify which designs achieve killing at lower tested concentrations. This evidence supports selection and refinement of infection-control strategies in bioengineering without relying only on visible growth suppression.
First, perform broth dilution across concentrations of the antibacterial agent. After identifying tubes or wells without visible growth, transfer samples from those conditions onto drug-free agar. Examine the agar for colony formation and record the lowest concentration with no colony growth. This sequence connects growth screening with a direct check for surviving bacteria.
Testing requires an antibacterial agent, a defined bacterial population, broth-dilution tubes or wells, and drug-free agar. The broth system identifies concentrations with no visible growth, while the agar provides the follow-up environment for detecting colony formation. Together, these components support a concentration-based measurement of bactericidal performance.
In bioengineering, researchers can apply MBC measurements to antibiotics, antimicrobial materials, surface coatings, and engineered delivery systems. The method supports comparisons against a defined bacterial population and identifies concentrations associated with killing. These results can guide the design of more effective infection-control strategies rather than evaluating performance through growth suppression alone.
The lowest tested concentration qualifies only when the transferred sample produces no colony growth on drug-free agar. If colonies appear, surviving bacteria remain detectable at that concentration, even when the broth showed no visible growth. This interpretation prevents temporary inhibition from being mistaken for bactericidal activity and supports clearer comparisons among tested options.